1. Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell cultures

   • Micheline McCarthy
   • Irving Vidaurre
   • Rebeca Geffin

   OriginalPaper Pages: 333 - 348

2. Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis

   • C. Griffith
   • F. Bagnato
   • S. Jacobson

   OriginalPaper Pages: 349 - 355

3. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment

   • Valerie Wojna
   • Richard L. Skolasky
   • Avindra Nath

   OriginalPaper Pages: 356 - 364

4. Innate and adaptive host response during the initial phase of herpes simplex virus encephalitis in the neonatal mouse

   • Guttalu K. Kumaraswamy
   • Ming Ming Fu
   • John J. Docherty

   OriginalPaper Pages: 365 - 374

5. The stability of herpes simplex virus type I genomes in infected Vero cells undergoing viral induced apoptosis

   • Ying-Hsiu Su
   • Xianchao Zhang
   • Timothy M. Block

   OriginalPaper Pages: 375 - 386

6. Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection—The Hawaii Aging with HIV Cohort

   • Victor Valcour
   • Priscilla Yee
   • Ned Sacktor

   Short Communication Pages: 387 - 391

7. Comparison of inflammatory infiltrates in trigeminal ganglia of cattle infected with wild-type Bovine herpesvirus 1 versus a virus strain containing a mutation in the LR (latency-related) gene

   • Sandra Perez
   • Luciane Lovato
   • Clinton Jones

   Short Communication Pages: 392 - 397

8. Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus

   • Mark P. Burgoon
   • Yupanqui A. Caldas
   • Gregory P. Owens

   Short Communication Pages: 398 - 402

9. Valproic acid does not affect markers of human immunodeficiency virus disease progression

   • Beau M. Ances
   • Scott Letendre
   • HNRC Group

   Short Communication Pages: 403 - 406

10. Failure of therapeutic coma and ketamine for therapy of human rabies

    • Thiravat Hemachudha
    • Buncha Sunsaneewitayakul
    • Alan C. Jackson

    Case Report Pages: 407 - 409